The validation stage plays a critical role in the development and production of medical devices; it ensures new medical devices meet all the functional, reliability and quality requirements of both customer and regulatory authorities. This paper presents a case study concerning validation and qualification process for medical devices in a UK-based medical device manufacturer. The work aims to develop an efficient and highly reliable procedure for the validation of medical devices. A benchmarking study has been performed to identify the best practices in product validation. The existing practices within the case study manufacturer have been reviewed to identify opportunities for validation improvement. New practices have been proposed for the case study manufacturer, and guidelines for implementing the proposed validation procedures have also been developed. Keywords: medical device; quality control; validation; qualification; benchmarking.
Introduction
Product validation and qualification is a highly constrained process, where different requirements from the involved actors (production, facilities, customer, industry and government regulations, etc.) must be satisfied; an improved more efficient manufacturing process resulting from the validation and qualification process will normally achieve significant savings on product development time and cost.
In the medical device sector, validation and qualification of a new product development process plays a critical role, it needs to meet more requirements than with general products due to its critical impact on human health. This validation stage needs to ensure produced medical devices fulfil the relevant regulations and satisfy all the customer requirements safely and successfully. Normally end users views are more appropriately directed towards the proposal of requirements, and engineers are the enactors of the validation process to ensure the requirements are met; in the realisation of this interviews were conducted with engineers in manufacturing organisations, rather than end users. This research work has been conducted within a UK medical device manufacturer. This manufacturer does not have an effective readily available validation process for their medical products, but they are required to have a validated manufacturing process to meet the quality requirements of the medical device they produce. This work aims to develop a standard, effective and efficient method for validating medical product production processes within a case study medical device manufacturer.
Current medical device validation processes
The importance of a strategic approach to product development in the manufacture of medical devices is emphasised by Hourd and Williams (2008) in their study of approaches taken by small and medium medical device manufacturers in the UK. Such an approach must incorporate a suitable validation process at its core, though the selection of a holistic methodology for the validated manufacture of a particular device is not straightforward.
At present a number of medical device validation processes and protocols exist. The work of Boatman (2013) provides a comparison of the two process validation standards provided in the USA. As described by Boatman (2013) both the Global Harmonization Task Force (GHTF) validation standard and the US Food and Drug Administration's (FDA) both provide process validation guidance. Differences exist in the standards in that the FDA guidance is more stringent, in its recommendation that the monitoring regime set up at the process qualification stage should continue until an estimate of variability can be established, than the GHTF guidance (Boatman, 2013; FDA, 2008) . Similarly in dealing with risk management GHTF highlights fault tree analysis and failure mode effects analysis in comparison the FDA's recommendation of design of experiments for that activity (Boatman, 2013) . While noting that the use of two separate standards for validation can be confusing, Boatman (2013) concludes that a firm utilising documented risk assessment, 'sound statistical principles' and has a monitoring system in place to track and highlight changes in a validation process over time is likely to already be compliant with both standards. Similarly, Aleem et al. (2003) highlights the use of the FDA guidelines and justifies the use of process validation as a practice with the comment that the consistent production of a product to set standards is only possible if the process used to produce the product also meets quality standards. An additional commentary on medical device regulation relating to the Canadian market and medical device export from that country may be found in McAllister and Jeswiet (2003) .
In Europe two directives are in place regarding the manufacture of medical devices, The Medical Devices Directive 93/42/EEC (MHRA, 2016a) and the In Vitro Diagnostic Medical Devices Directive 98/79/EC (MHRA, 2016b) . Both directives make reference to the manufacturing process and requirements for documentation in order that the CE certification marking can be awarded to the produced products [a further discussion of European regulations can also be found in French-Mowat and Burnett (2012)]. Tan et al. (2015) make the point that is essential to know whether or not the device in question will be validated as a medical or an electronic device as the regulations for both options differ. In addition an innovation may be marketed as a 'device for medical, fitness, research purposes or an app for mobile devices' (Tan et al., 2015) . An additional commentary on conformity and validation standards used in countries around the world may be found in Lamph (2012) and Gupta (2016) .
In addition to these guidelines advice on the management of electronic documents applicable for medical device process validation are provided by the FDA (2016), Medicines and Healthcare Products Regulatory Agency (MHRA, 2016c) and Therapeutic Goods Administration (TGA, 2016) . According to Kale (2013) , countries such as Mexico and Brazil have adopted existing standards such as provided by the USA and Europe, suggesting that these standards set a global base line for device validation. This notion is backed by a number of works in literature that have attempted to apply process methodologies developed in the aerospace industry. The research of Lalli and Vargo (1972) references the work of NASA who developed an extensive reliability and quality assurance methodology that could be used as the bases for an appropriate program for medical instrumentation. This space-related methodology was based on the application of two existing engineering disciplines:
1 reliability 2 quality assurance (Lalli and Vargo, 1972) .
According to the author's definitions, "reliability engineering is concerned with design and testing tasks in product development to ensure that the product is properly designed to perform the assigned task without failure" (Lalli and Vargo, 1972) . Alternatively, "Quality Assurance is concerned with various control methods and qualification testing to ensure that the product delivered is manufactured as designed" (Lalli and Vargo, 1972) . In summary, Lalli and Vargo (1972) make the case that it is essential to monitor and control the manufacturing and test processes and to maintain close adherence to specifications, parts must be standardised as much as possible and good housekeeping practices must be followed at all times and in all places. In this respect these recommendations closely mirror those of the FDA and other regulatory authorities (FDA, 2008; Long et al., 2011) . A major component of modern medical devices is software. While not putting forward additional standards the work of Jiang and Mangharam (2015) describes a number of approaches for effective design and development of medical devices related software [with further commentary on this subject provided by Carroll and Richardson (2016) ]. From literature, the authors have identified two specific knowledge gaps in the implementation of process validation for medical devices:
• there is no harmonised view regarding which practices and procedures are required to effectively address the validation stage
• analysis related to the resource infrastructure and investment required for developing a fully reliable and efficient process validation phase is very limited.
In order to address these deficiencies validation practices within the aerospace sector have been investigated in the form of a benchmarking study.
Research methodology
In order to develop a standard, effective and efficient process for validating medical product production process, a cross-industry benchmarking study was conducted. The aerospace sector was the focus of the benchmarking due to the high quality and safety requirements of aerospace products, which are shared by medical products. Both aerospace products and medical devices are critical for complying with customer and end-user requirements. The development of a validation and qualification process for medical devices has been carried out by following the methodology shown in Figure 1 . The methodology includes four phases: industry internal process analysis, cross-industry benchmarking, result analysis and proposal, implementation and monitoring.
• Phase 1 Industry internal process analysis: A qualitative analysis was performed on the current practices, challenges and improvement requirements for medical device validation and qualification within the case study manufacturer (of medical devices). This analysis was mainly conducted based on semi-structured interviews with relevant personnel (designers, engineers, managers, and customers). In addition, the internal qualification and validation procedures, standards and resources allocated to process validation were also reviewed.
• Phase 2 Cross-industry benchmarking study: A benchmarking study was undertaken within the aerospace sector. This study was carried out through several techniques and sources, including an extensive literature review, consultation of benchmarking databases, corporate websites and publications, and seven direct semi-structured interviews.
• Phase 3 Best practices analysis and proposal: Qualitative analysis was done on the outcomes and findings of the benchmarking study. A list of practices for the validation process was proposed. Improvement requirements were taken into account in proposing the validation practices for medical devices; the proposals were validated by a panel of experts.
• Phase 4 Implementation and monitoring: The implementation guidelines for new validation practices were developed in order to integrate the proposed validation practices into the production process within the researched company. The feedback and recommendations from the panel of experts on the practice implementation, the expected benefits and associated complexity and resource requirements were considered for the development of the guidelines. • Literature Review • Elaboration of questionnaire • Selection of participants.
• Benchmarking campaign.
• 
Internal validation process analysis
The existing internal validation process was reviewed and analysed first.
Data collection
The existing data and information related to the validation and qualification process were collected from the case study manufacturer's quality management system (QMS) procedures, semi-structured interviews with the relevant employees, and direct observation in medical device validation within the case study manufacturer.
Company QMS procedures
The QMS within the company was reviewed, and it was found that the company is certified by ISO 9001:2008 Quality Management and ISO 13485:2003 Medical Device Quality Management Systems.
Interviews
Several semi-structured interviews were carried out. The questionnaire included three sections, i.e. general information, process validation, and resources required for validation. General information questions were asked about the roles within the company, years of experience and key functions and responsibilities in the department; the process validation questions focused on specific tasks, activities, procedures, workflow, and performance during the medical device validation stage; In addition, the allocation of resources in the validation of medical devices was ascertained by the questionnaire.
Three initial interviews were conducted with current operators of medical device validation in order to finalise the questionnaire. In total, ten employees from different departments within the researched medical device manufacturer were interviewed as briefed in Table 1 . Table 1 Internal analysis interviewees
Area Role

Management
• Managing director
• Production manager Quality assurance
• Quality assurance manager
• Quality assurance engineer Production manager/manufacturing • Mould shop manager
• IT department manager
Direct observation
The researcher (third author in this paper) was working as a member of the Quality Assurance Department within the case study manufacturer during the project period. Data and information were collected by the author's direct observation on the current process validation through various tasks and activities:
• drafting and generation of validation related documentation
• carrying out protocols and reporting
• sample data collection and testing
• technical documentation research
• feedback from OEM and customers
• QMS procedures update.
Data analysis
A qualitative analysis was performed on the data and information collected. The analysis was focused on evaluating the current status and comparing it to the desired validation process, identifying the improvement areas by considering those process aspects that have potential negative impact on product quality, reliability, traceability, time, cost, installations and equipment, and customer's satisfaction. An initial analysis was reviewed and validated via a workshop to form the current internal validation process within the researched manufacturer. The workshop involved several experts and stakeholders across the company being responsible for the development and manufacturing of medical devices. This workshop panel was composed of the managing director, quality assurance manager, design leader and engineers, IT manager, and test lead operator.
Result of analysis
Outputs of the internal validation process analysis have been split into two categories: procedures and resources:
• procedures (P): issues related with the work flow in place, instructions and orders that may affect the overall performance of the process validation
• resources (R): issues related with the lack or inefficient assignation and distribution of resources (human resources, time, material, equipment etc.) at each stage of the validation process. Table 2 summarises the results of the internal evaluation of the company's current validation practices. The findings regarding the current validation practices in the researched company are presented below:
Documentation management
As requested by the Regulatory Authorities, in this particular case the FDA in the USA, all medical companies are required to maintain a secure, comprehensive and centralised system to manage all quality procedures, product documentation and manufacturing procedures, as well as tracking all the changes made in the medical product development (Northrop Grumman, 2012) . In addition, the documentation management system (DMS) should be capable of identifying all the documents impacted by quality events and product changes. Within the researched company, the internal validation protocols and reports are fully generated on a MS Word ® processor. The validation related documentation contains several attachments which normally are in different file formats (images, PDF file, CAD drawings, etc.), as shown in Figure 2 . In the current documentation practice, documents are not appropriately structured and configured; the company does not exploit all the advantages of documentation software, which makes the protocol and report drafting process more difficult and tedious. In addition, a considerable amount of time is dedicated to deal with an inadequately structured and configured validation documentation system. Even further, some difficulties associated with the distribution and revision control of documents and drawings have been found.
Risk assessment
Risk assessment analysis (process failure mode effect analysis -pFMEA) is one of the customers' requirements prior to the completion of the performance qualification. Although pFMEA is covered by the current company procedures, the actual process does not follow the provided guidelines, which results in considerable deviations and approval issues. The current risk assessment practices are illustrated in Figure 3 , where OQ represents operational qualification and PQ represents performance qualification. R1, R2, and R3 dictates the ERP, personnel and training aspects of the validation process referred to Table 2 . 
Protocol/ Report
One 
Communication
It has been observed that some orders and request procedures (production runs, test activities, calibration, engineering change requests, etc.) within the researched company are not totally effective, resulting in unnecessary delays and potential causes of confusion and errors. Figure 4 shows the current communication scheme. As can be seen, there are communication channels between Quality Assurance Department and Design, Production teams and customers, however there is communication disconnection between the Quality Assurance Department and other functional areas within the company. 
QUALITY ASSURANCE DEPARTMENT
CUSTOMER
Communications with the customer are mainly managed by e-mail and conference calls. There is a limitation of the file and document size which can be sent enclosed in the messages. The validation related document file-size is constantly increasing and this is becoming a major problem.
In addition, documentation are not in a standardised format, wording or even location, which results in difficulties in interpreting the commands and providing and prioritising the appropriate resources to resolve quality issues.
Identification and traceability
Analysis shows that the tool and calibration databases, component identification and traceability (parts, raw material, tooling, etc.) should be improved. Procedures developed in this field need to meet the requirements provided by the FDA, which states that medical device manufacturers should maintain a system to track all materials and associated suppliers used in production (Parry et al., 2003) .
In addition to this, the company plans to step forward and implement a barcode or RFID technology-based identification and tracking solution.
ERP software
Although there is an enterprise resource planning (ERP) system in place in the organisation, it is not fully implemented within all the departments and divisions in the company. The total implementation feasibility of an ERP solution has been suggested by external auditors to be evaluated as an improvement in the IT structure of the company.
Personnel
During some periods of the validation process, a considerable amount of activities are accumulated, which results in workload peak-demands that occasionally restrict personnel availability.
Training
Training in validation related software (e.g. Statistical Process Control Software) and other computer skills (e.g. ERP) are currently not considered for all the personnel involved in process validation. The training and qualification should be provided to more directly involved personnel, not only on the validation process but also on the tools and resources related to them, such as facilities, material, IT network etc.
Benchmarking study
The benchmarking study in this work was aimed to evaluate the leading practices on process validation in other industrial sectors. The aerospace industry was particularly selected because of the high quality and safety requirements of aerospace products, a factor commonly shared by medical products. Both aerospace products and medical devices are critical for complying with customer and end-user requirements.
Benchmarking scope
The benchmarking boundaries were initially set within the UK aerospace and defence manufacturing industry. However, due to limited available information about process validation and qualification, aerospace organisations both inside and outside the European Union were also included for the benchmarking.
Data collection
Selecting approaches for benchmarking
Data collection approaches were reviewed and qualitatively compared in two aspects: requirements of the approach and information to be gained by the approach. Figure 5 illustrates the comparison between those benchmarking approaches, i.e. personal visit approach, interview approach, and online survey approach, and public information review. 
HIGH LOW
Source: Andersen and Pettersen (1996) Due to the characteristics of the data and information sought in the benchmarking, i.e. the time and resource constraints, as well as external factors (the availability or willingness of the potential collaborators to take part in the study etc.), publicly available resources and live interviews were mainly used for collecting data and information in this study.
Publicly available information
Below classified public information were sought for the benchmarking:
• literature: books, journal papers, articles, specialised magazines etc.
• conference papers and presentations
• online benchmarking best practices databases
• professional association websites and forums
• corporate brochures and websites
• technical reports.
Interviews
A series of interviews with different participants from the aerospace sector were undertaken. These interviewees were chosen according to their role within the organisation, years of experience, business activities of the company, level of involvement within process validation activities, willingness to take part in the study and their availability. For the benefit of confidentiality, none of the participants and the respective companies involved in these interviews is named. An overview of the participants in the interviews is provided in Table 3 . The benchmarking interviews were conducted using a semi-structured questionnaire which included the questions about the process validation and resources required. The process validation related questions were focused on the practices and procedures employed by the interviewee and his/her organisation for achieving different requirements and goals in validation stage. The process validation questions also covered the main difficulties encountered in the validation stage and the human resources, such as team organisation and role assigning for the activities of this phase were also included. The resource related questions were intended to understand means, tools and resources available for performing validation tasks.
Benchmarking findings
The main outputs of the benchmarking study are outlined as below, the index of P1, P2, P3, P4, R1, R2, R3 are referred to Table 2 in the below sections.
Documentation management (P1)
P1.1 Independent modules: it has been found the different elements/entities that compose one validation document are created separately. The final document is created/assembled when all the elements/entities are completed.
P1.2 The role of the PDF type document: The PDF type file acquires more relevance within the documentation workflow, not only for final deliverable documents, but also for the intermediate documents in daily work.
PDF editor software is crucial for good management of these resource files.
P1.3 Interactive master lists:
In the organisation with no ERP implemented in the evaluated departments, documentation master lists are widely used to keep all the relevant files organised. As a value added feature to this, references and hyperlinks are utilised in the documents for the purpose of time saving and improved organisation (Garretson and Harmon, 2005) .
P1.4 DMS: Four out of seven of the participants interviewed showed that within their organisations a DMS module as an add-on of their ERP was in place for the generating, editing and managing all the relevant documentation. By doing this, the time for documentation administration was greatly reduced.
Risk assessment (P2)
P2.1 Use of FMEA: All the participants confirmed that the FMEA as a risk assessment tool was widely used at some stage of the validation of a new design, resulting in a helpful method for detecting possible errors, failures and risks.
The use of FMEA also encouraged the creation of a teamwork environment where engineers from different functional departments can gather together to discuss the possible setbacks on the product development flow.
P2.2 FMEA documentation/templates: It has been found that a common structure and functionality of the FMEA document is normally in place despite some minor modifications that are needed for the development of specific products and processes. Effective documentation enables the FMEA traceability of the evaluated requirements during the manufacturing process, it also allows the quality management department to trace problems effectively and mitigate the identified risks.
P2.3 FMEA procedures: No practical details for the FMEA procedures were obtained from the live interviews with any of the participants. However the literature review found that some variations exist in the pre and post analysis meetings of FMEA, also the investment of resources (time, software, teams) in this FMEA procedure tends to lead to sound improvements in the current work flow.
In particular, literature suggested that the role of 'analysis conductor' or 'facilitator', regarded as responsible for managing the FMEA process and enhancing the effectiveness of the analysis, shall excel in organising, encouraging participation and managing discussion in the FMEA (Andersen and Pettersen, 1996) .
P2.4 FMEA software: The interviews found that there is dedicated software for the FMEA stage in the three organisations interviewed, leading to a dynamic and user-friendly process allowing participants to concentrate in the analysis rather than in the documentation generation.
In the other four organisations, a standard MS Excel-based spread-sheet template was proved sufficient for their purposes.
Communication (P3)
P3.1 Online video-conference calls: Four out of the seven consulted participants, when meetings are required with external branches of the organisation or customers, often use online live video-conference calls to deal with major updates, changes or critical reunions. It is commonly agreed that these have resulted in increased efficiency, time saving, constructive and positive experiences.
P3.2 Review stages: Down the workflow of the documentation draft and generation process, several review stages are established prior to the approval release (Lockheed Martin, 2016a) . In these reviews, different parts of the department responsible for the document generation are involved in order to assure the accuracy, error-free, quality and correctness of the documents produced.
P3.3 'In-cloud' services: The interviews found that 'in-cloud' service is regarded as a reliable new data and information sharing method in contrast to the common services based on intranet servers.
Identification and traceability (P4)
P4.1 Shop floor data collection: Five out of seven participants stated that shop floor data collection methods were widely used across their organisation, where job cards-based methods are the most common method. Particular procedures and examples for these data collection methods were also evidenced by the literature (Watts, 2008) .
P4.2 Bar-codes: Bar-coded systems are used by all interviewee organisations. The benefits of using a bar-code system include the elimination of operator key strokes, elimination of record-keeping errors, improved work environment, reduced operating time and improved efficiency (Lockheed Martin, 2016b).
P4.3 RFID technology: RFID technology allows information stored in tags attached to components to be collected for tracing product flow through processes. Within the four companies that are directly involved in manufacturing and maintenance activities, keeping track and locating the vast array of specific tooling and jigs in their facilities represents a big challenge.
ERP (R1)
All the participants of the interviews assured that an ERP solution is implemented within their organisations. In addition to this, total implementation is applied within all the departments related to validation processes (manufacturing, production, quality assurance, procurement). According to the interviews and the literature review (Watts, 2008) , the main benefits from ERP total implementation include a greater control and visibility of the manufacturing related activities, real-time access to accurate data, improved forecast, better resource allocation and cost management.
Personnel (R2)
Depending on the characteristics of the organisation analysed and interviewed, diverse answers were received on the availability and distribution of human resources, the assignation of responsibilities and the specific tasks and activities of the departments and roles involved in process validation.
Training (R3)
R3.1 Training catalogue: All of the organisations have implemented a training catalogue where different courses, training and workshops are offered to their employees, which enables the organisation to select appropriate employees for process validation according to a set of specific factors, such as their positions, skills or shift availability.
In addition, the importance of the role of the trainer has been appreciated by the consulted organisation in the interview, motivation and communication skills are also seen as critical for appropriate connecting and knowledge transmission.
R3.2 Online training resources: Two of the organisations have incorporated online corporative tools for personnel development. By providing this, the responsibility of skills and capacities development is transferred to the individual employees in the process validation. The e-learning framework and catalogue is available on the corporate intranet, where employees can access desired training courses based on their specific skill set.
Proposals development and validation
Elements and practices in process validation have been reviewed to identify the ones that could be successfully translated to the investigated medical device manufacturer in this research. Below factors were taken into account in the identification and generating a proposal:
• time and material resources available
• engineers, operators and other employees' implication
• management level commitment
• customer requirements and expectations
• regulatory authorities' compliances.
Based on the above consideration, a set of scores (between 1 to 5 where 1 means very low and 5 means very high) related to the benefits and complexity (defined as the amount of effort required or type of resource needed) of implementation have been established based on collected views of the engineers in the investigated company, as shown in Table 4 . From this table, 'instant winners' (those practices that share a high score of benefit and low scores of complexity) can be identified. 
Documentation management
Documentation management desires a clear, structured and user-friendly documentation system. In order to comply with possible future regulations, the documentation system should ensure integrity, accuracy and reliability of the information, especially the documented evidences related to process validation. Moreover, the system shall provide some type of audit trail to prevent and detect unauthorised creation, addition, alteration or deletion of records. The main proposals for this area are summarised below:
• new documentation structure: commencing with process validation related files and the progressive implementation across other departments and functional areas of the organisation
• master lists of documents with hyperlinks
• update/procurement of documentation edition and management software
• quality control database: review and update QMS documentation procedures; apply documentation revision control; publish QMS on the intranet for accessible consulting.
Risk assessment
A new template for the FMEA analysis is proposed in order to capture all the information required, provide more dynamism to the evaluations and enhance the achievement of results. In addition to this, a procedure for risk assessment is suggested as shown in Figure 6 , i.e., an FMEA task is coordinated by the FMEA core team with the active involvement of function team leader, facilitator, champion/sponsor, and document recorder. 
Communication
With the aim of improving the communication within the investigated manufacturer, the following proposals are made in two groups: procedure related and resource related.
1 Regarding procedures review, gap analysis, improvement opportunities and update, the following proposals are made:
• require that team meetings and panel analysis reviews occur prior to critical points in the schedule such as non-conformances or any major changes to the product
• add additional review stages prior to the release of any documentation
• have regular (weekly) project status review meetings at critical stages of the schedule, major deliverables, and high concentrations of activity
• have regular (weekly, monthly) advisory circulars with project status, summary, upcoming events etc.
• make QMS manual, procedures, and instructions more accessible to employees.
2 Resources allocation related proposals are:
• provide web based 'in-the-cloud' information sharing applications
• adopt video-conference calls technology
• provide a QMS intranet.
Identification and traceability
Identification and traceability requires implementation of shop floor data collection to capture the process parameters, in order to have an accurate picture of the manufacturing workflow and efficiency indicators, and also to meet the FDA requirements for full-traceability system. It is proposed that the following information should be collected from the workshop by operators:
• estimated times for jobs and operations
• quality tolerances
• labour and quantity costing
• automatic job receipt, material issue, lot and serial number entry
• real time information and validation For a mid-term scenario, bar-code-based system is proposed to collect the shop floor operation information, which will greatly increase operators' efficiency and avoid mistakes originated by handwriting.
ERP
It is proposed to implement an ERP solution for a longer term within the investigated company in order to centralise all current systems into one. Particularly in the area of process validation, the quality assurance (QA) module would allow for the proper definition of procedures, tests, and audits. The QA module can be triggered directly within the ERP system to capture and process specific data. This solution enables the automation of production process reviews about machines, operators, inspection reports, raw material supply etc.
Training
Training and personnel development plays a key role in process validation. Within the investigated company only an ISO 13485:2003 training course is given by the department currently, a corporate skill development program is proposed to cover the essential skills of learning, advanced developments and corporate culture. A wider catalogue of workshops, courses and activities are also proposed for the following aspects:
• IT skills (general, documentation, statistical analysis etc.)
• introduction to regulatory framework (FDA, GMP, GHTF etc.)
• risk assessment
• quality culture.
Validation of results
For definition and development of new validation procedures, it is crucial to validate and authenticate the practices with the organisation and its employees in order to ensure that the requirements are met and no conflicts arise from their implementation. Two stage validations were carried out with both management level positions and specific product validation teams and operators to validate the proposed validation and qualification practices in this study.
The first stage validation was conducted with five key experts including the Quality Assurance Department manager, a quality assurance engineer, the production manager, the design leader engineer and the IT department manager within the sponsor company. The second stage validation was conducted with the principal members in the company, including a manager; two engineers from the Quality Assurance Department, the medical devices test lead operator, the design engineer and the managing director of the organisation. Different procedures and resources in the proposed validation practices were assessed, and the proposals have been confirmed feasible and effective for medical device validation and qualification purposes in the investigated company.
Implementation
This section develops guidelines for implementing the validations process within the researched company. The resource and cost elements along with resulting quality improvements have been considered in the development of implantation guidelines for both the short and long term durations.
Short term recommendations
Documentation system management
A new documentation structure for the validation related protocols and reports are suggested for implementation in the short term as shown in Figure 7 . It is proven by practice that up to 90% of time saving can be made in generating process validation related documentation by adopting this new documentation structure while requiring only limited investment on software purchasing and training.
Identification
The use of 'job route-cards' is suggested for implementation to provide the ability for shop floor data-collection within the manufacturing process.
A template for the shop floor data-collection card should be validated by the engineers and operators involved in the manufacturing process. The content and datafields of the card should be linked to the information database through the current production ERP system, assuring the accuracy of the data and providing performance metrics, transparency and full-traceability. External Reports:
i.e Calibration Reports
Photos, Images, Drawings.
Final PDF
No Conversion Need Independent Documents
Communication procedures
Several modifications are proposed for implementation in order to address the communication challenge within the investigated company:
• update of internal procedures: e.g. the requirement for confirmation meetings as 'checkpoints' before major changes during the work-flow and intermediate and final review stages for newly produced documentation
• implementation of new communication channels: e.g. improve the current IT infrastructure; use new online collaborative software tools and 'in-the-cloud' services.
Risk management
FMEA related procedures and work-flow are suggested. An updated template for the FMEA analysis has been suggested for implementation. By using this template, the number of participants and different roles involved in the analysis performed within the project can be increased; realising that its use can result in a wider range of opinions on the different requirements evaluated in this process.
Long term recommendations
ERP
Total implementation of ERP system across the organisation is suggested, as this is believed to be able to improve the efficiency and enhance the visibility of different actions during the validation stage, providing transparency to the quality related issues, increasing the reliability of documentation management, reducing risks and removing non-value adding processes to improve the efficiency of the department/s. However the total implementation requires a consideration of the substantial investments associated.
Training
It was proposed to enhance the training in validation and qualification processes.
Identification: bar-code system
The bar-code system is proposed to identify components in the shop floor, which enables the total implementation and successful integration of the shop floor data collection cards and this consequently will optimise the used resources.
Conclusions
This research has conducted comprehensive analysis of the leading practices of process validation in both medical device production and the aerospace industry. The research promotes the identification of:
• the key points and procedures within the process validation stage in order to ensure the manufacturing of highly reliable and quality products
• the practices, knowledge and resources required to optimally address each activity through process validation
• the interactions and exchanges between these factors and how they shape and modify the process validation.
A number of practices in use within aerospace companies were identified as being highly relevant to the improvement of processes within the medical devices sector. Dividing into short term and longer term the recommendations for the case study manufacturer are as follows:
1 Short term
• The new documentation framework identified in this paper has been implemented in the case study manufacturer. It has been demonstrated that the new framework provides the capacity to achieve time reductions of up to 90% in the generation of process validation related documentation.
• The implementation of 'job route-cards' provides the ability for shop floor data collection within the manufacturing process, which will result in clearer and more accessible information for the subsequent process validation stage.
• Use of confirmation meetings as' checkpoints' before major changes, during the work-flow, intermediate and final review stages for newly produced documentation.
• Implementation of new communication channels through improvement of current IT infrastructure, implementation and use new online collaborative software tools and 'in-the-cloud' services.
• Redesigned templates to streamline the risk assessment process.
Long term
• Total implementation of ERP system across the case study manufacturer is suggested, as this is believed to be able to improve the efficiency and enhance the visibility of different actions during the validation stage, providing transparency to the quality related issues, increasing the reliability of documentation management, reducing risks and removing non-value adding processes to improve the efficiency of the department/s.
• It is proposed to enhance the training in validation and qualification processes.
• The use of a bar-code system is proposed to identify components in the shop floor, enabling the total implementation and successful integration of the shop floor data collection cards and consequent resource optimisation.
It has been demonstrated that the organisations' operating in the aerospace industry have on the whole adopted automated management solutions within the four main activity areas: documentation management, quality management, product and programme management and review process; resulting in dramatic improvement in business performance and compliance with their relevant regulatory quthority requirements. On the other hand, medical device companies, while still delivering the required compliance, are still using combinations of paper-based processes and discrete IT solutions. The studied company uses a robust and consistent process validation strategy which has been proving to be successful when dealing with customer's requirements; but the inadequate definition of some procedures result in a loss of valuable resources in non-value adding activities. Although correct decisions were made regarding the major points in process validation, the derived and subsequent activities were not optimised. However, once particular areas have been highlighted in process validation, a numerical method for rating the different parameters involved may be helpful in assessing the effectiveness of the adopted practices.
Further research activities could be performed addressing the situation presented by the inclusion of higher levels of software within medical devices and the need for validation of future automated and perhaps partially autonomous functions programmed within such products. In a similar way the research of how aerospace companies perform within the product life-cycle approach environment would provide key findings for its further implementation within the presented approach. The benchmarking and recommendations put forward in this paper are flexible enough to also be of relevance to industries beyond the medical device sector.
